Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). Meeting Abstract (Web of Science)

Industry Collaboration International Collaboration

cited authors

  • Overman, Michael J.; LoRusso, Patricia; Strickler, John H.; Patel, Sandip Pravin; Clarke, Stephen John; Noonan, Anne M.; Prasanna, Thiru; Amin, Manik A.; Nemunaitis, John J.; Desai, Jayesh; O'Byrne, Kenneth John; George, Thomas J.; Englert, Judson; She, Dewei; Cooper, Zachary A.; Wu, Yuling; Khan, Anis; Kumar, Rakesh; Bendell, Johanna C.

publication date

  • May 20, 2018


published in



  • 36


  • 15